128 related articles for article (PubMed ID: 26998679)
61. Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics.
Chun C; Lee SM; Kim CW; Hong KY; Kim SY; Yang HK; Song SC
Biomaterials; 2009 Sep; 30(27):4752-62. PubMed ID: 19520429
[TBL] [Abstract][Full Text] [Related]
62. One-pot construction of functional mesoporous silica nanoparticles for the tumor-acidity-activated synergistic chemotherapy of glioblastoma.
Li ZY; Liu Y; Wang XQ; Liu LH; Hu JJ; Luo GF; Chen WH; Rong L; Zhang XZ
ACS Appl Mater Interfaces; 2013 Aug; 5(16):7995-8001. PubMed ID: 23869943
[TBL] [Abstract][Full Text] [Related]
63. Doxorubicin conjugated NaYF(4):Yb(3+)/Tm(3+) nanoparticles for therapy and sensing of drug delivery by luminescence resonance energy transfer.
Dai Y; Yang D; Ma P; Kang X; Zhang X; Li C; Hou Z; Cheng Z; Lin J
Biomaterials; 2012 Nov; 33(33):8704-13. PubMed ID: 22938822
[TBL] [Abstract][Full Text] [Related]
64. Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release.
Aryal S; Hu CM; Fang RH; Dehaini D; Carpenter C; Zhang DE; Zhang L
Nanomedicine (Lond); 2013 Aug; 8(8):1271-80. PubMed ID: 23409747
[TBL] [Abstract][Full Text] [Related]
65. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
[TBL] [Abstract][Full Text] [Related]
66. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.
Du JZ; Du XJ; Mao CQ; Wang J
J Am Chem Soc; 2011 Nov; 133(44):17560-3. PubMed ID: 21985458
[TBL] [Abstract][Full Text] [Related]
67. Nanoparticles generated by PEG-Chrysin conjugates for efficient anticancer drug delivery.
Zheng H; Li S; Pu Y; Lai Y; He B; Gu Z
Eur J Pharm Biopharm; 2014 Aug; 87(3):454-60. PubMed ID: 24691159
[TBL] [Abstract][Full Text] [Related]
68. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Lale SV; R G A; Aravind A; Kumar DS; Koul V
Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
[TBL] [Abstract][Full Text] [Related]
69. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery.
Lu PL; Chen YC; Ou TW; Chen HH; Tsai HC; Wen CJ; Lo CL; Wey SP; Lin KJ; Yen TC; Hsiue GH
Biomaterials; 2011 Mar; 32(8):2213-21. PubMed ID: 21176954
[TBL] [Abstract][Full Text] [Related]
70. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
71. PH responsive polypeptide based polymeric micelles for anticancer drug delivery.
Zhao D; Li B; Han J; Yang Y; Zhang X; Wu G
J Biomed Mater Res A; 2015 Sep; 103(9):3045-53. PubMed ID: 25689362
[TBL] [Abstract][Full Text] [Related]
72. Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery.
Lv S; Song W; Tang Z; Li M; Yu H; Hong H; Chen X
Mol Pharm; 2014 May; 11(5):1562-74. PubMed ID: 24606535
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of polymeric nanoparticle formulations by effective imaging and quantitation of cellular uptake for controlled delivery of doxorubicin.
Win KY; Teng CP; Ye E; Low M; Han MY
Small; 2015 Mar; 11(9-10):1197-204. PubMed ID: 25400129
[TBL] [Abstract][Full Text] [Related]
74. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
[TBL] [Abstract][Full Text] [Related]
75. Conjugated polymer and drug co-encapsulated nanoparticles for chemo- and photo-thermal combination therapy with two-photon regulated fast drug release.
Yuan Y; Wang Z; Cai P; Liu J; Liao LD; Hong M; Chen X; Thakor N; Liu B
Nanoscale; 2015 Feb; 7(7):3067-76. PubMed ID: 25608113
[TBL] [Abstract][Full Text] [Related]
76. Triggered release of doxorubicin from temperature-sensitive poly(N-(2-hydroxypropyl)-methacrylamide mono/dilactate) grafted liposomes.
van Elk M; Deckers R; Oerlemans C; Shi Y; Storm G; Vermonden T; Hennink WE
Biomacromolecules; 2014 Mar; 15(3):1002-9. PubMed ID: 24476227
[TBL] [Abstract][Full Text] [Related]
77. Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release.
Basuki JS; Duong HT; Macmillan A; Erlich RB; Esser L; Akerfeldt MC; Whan RM; Kavallaris M; Boyer C; Davis TP
ACS Nano; 2013 Nov; 7(11):10175-89. PubMed ID: 24131276
[TBL] [Abstract][Full Text] [Related]
78. Design of multifunctional alkali ion doped CaF2 upconversion nanoparticles for simultaneous bioimaging and therapy.
Yin W; Tian G; Ren W; Yan L; Jin S; Gu Z; Zhou L; Li J; Zhao Y
Dalton Trans; 2014 Mar; 43(10):3861-70. PubMed ID: 24442070
[TBL] [Abstract][Full Text] [Related]
79. pH-sensitive Laponite(®)/doxorubicin/alginate nanohybrids with improved anticancer efficacy.
Gonçalves M; Figueira P; Maciel D; Rodrigues J; Qu X; Liu C; Tomás H; Li Y
Acta Biomater; 2014 Jan; 10(1):300-7. PubMed ID: 24075886
[TBL] [Abstract][Full Text] [Related]
80. Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier.
Niu J; Huang A; Xiao Y; Su Z; Li H; Ping Q; Bao X; Li S; Chen Y; Sun M
J Drug Target; 2013 May; 21(5):415-26. PubMed ID: 23597028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
